XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Net Loss per Share (Tables)
3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Anti-dilutive securities excluded from the computation of earnings per share
The following potentially dilutive securities were excluded from the computation of earnings per share as of March 31, 2023 and 2022 because their effects would be anti-dilutive:
 
    
March 31,
 
    
2023
    
2022
 
Common stock warrants
     3,658,520        3,610,743  
Assumed conversation of preferred stock warrants
     11,896,667        —    
Assumed conversion of preferred stock
     8,681,176        1,135,721  
Assumed conversion of convertible notes
     488,031        488,031  
Stock options
     2,894,393        2,238,103  
    
 
 
    
 
 
 
Total
     27,618,787        7,472,598  
    
 
 
    
 
 
 
Summary of reconciliation of weighted average shares outstanding calculation The following table provides a reconciliation of the weighted average shares outstanding calculation for the three months ended March 31, 2023 and 2022:
    
Three months ended March 31,
 
    
2023
    
2022
 
Weighted average shares issued
     10,081,634        7,906,728  
Weighted average
pre-funded
warrants
     1,540,750        283,755  
    
 
 
    
 
 
 
Weighted average shares outstanding
     11,622,384        8,190,483